Vor Bio price target lowered to $32 from $55 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Vor Bio (VOR) to $32 from $55 and keeps a Buy rating on the shares. The firm cites share dilution from the capital raise and adjustments to reflect the company’s opportunity in Sjogren’s disease for the target cut.